There were 32 patients with CV2/CRMP5‐IgG positivity, 4 were excluded due to short follow‐up (<2 months), and 1 was excluded due to alternative diagnosis (progressive multifocal leukoencephalopathy) (Figure S1). This evidence concerns the gene DPYSL5 and progressive multifocal leukoencephalopathy.